4//SEC Filing
Pacala Mark L 4
Accession 0001799191-22-000039
CIK 0001799191other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:34 PM ET
Size
6.1 KB
Accession
0001799191-22-000039
Insider Transaction Report
Form 4
Pacala Mark L
Director
Transactions
- Award
Common Stock
2022-11-17+2,160→ 52,780 total - Award
Common Stock
2022-11-17+29,057→ 81,837 total
Footnotes (1)
- [F1]Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001321250
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:34 PM ET
- Size
- 6.1 KB